Rohini Roy, Jarin Chun, Simon N Powell. Nat Rev Cancer 2011
Times Cited: 791
Times Cited: 791
. Nature 2011
Times Cited: 4873
Times Cited: 4873
List of shared articles
Times cited
Expression Profiling in Ovarian Cancer Reveals Coordinated Regulation of BRCA1/2 and Homologous Recombination Genes.
Noélia Custódio, Rosina Savisaar, Célia Carvalho, Pedro Bak-Gordon, Maria I Ribeiro, Joana Tavares, Paula B Nunes, Ana Peixoto, Carla Pinto, Carla Escudeiro,[...]. Biomedicines 2022
Noélia Custódio, Rosina Savisaar, Célia Carvalho, Pedro Bak-Gordon, Maria I Ribeiro, Joana Tavares, Paula B Nunes, Ana Peixoto, Carla Pinto, Carla Escudeiro,[...]. Biomedicines 2022
BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling.
Melissa Bradbury, Eva Borràs, Josep Castellví, Olga Méndez, José Luis Sánchez-Iglesias, Assumpció Pérez-Benavente, Antonio Gil-Moreno, Eduard Sabidó, Anna Santamaria. Sci Rep 2022
Melissa Bradbury, Eva Borràs, Josep Castellví, Olga Méndez, José Luis Sánchez-Iglesias, Assumpció Pérez-Benavente, Antonio Gil-Moreno, Eduard Sabidó, Anna Santamaria. Sci Rep 2022
Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis.
Yinan Xiao, Meiyu Bi, Hongyan Guo, Mo Li. EBioMedicine 2022
Yinan Xiao, Meiyu Bi, Hongyan Guo, Mo Li. EBioMedicine 2022
BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors.
Mattia Cremona, Cassandra J Vandenberg, Angela M Farrelly, Stephen F Madden, Clare Morgan, Roshni Kalachand, Jessica N McAlpine, Sinead Toomey, David G Huntsman, Liam Grogan,[...]. Br J Cancer 2022
Mattia Cremona, Cassandra J Vandenberg, Angela M Farrelly, Stephen F Madden, Clare Morgan, Roshni Kalachand, Jessica N McAlpine, Sinead Toomey, David G Huntsman, Liam Grogan,[...]. Br J Cancer 2022
Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome Resistance.
Satoru Kyo, Kosuke Kanno, Masahiro Takakura, Hitomi Yamashita, Masako Ishikawa, Tomoka Ishibashi, Seiya Sato, Kentaro Nakayama. Cancers (Basel) 2022
Satoru Kyo, Kosuke Kanno, Masahiro Takakura, Hitomi Yamashita, Masako Ishikawa, Tomoka Ishibashi, Seiya Sato, Kentaro Nakayama. Cancers (Basel) 2022
Cellular Mechanism of Gene Mutations and Potential Therapeutic Targets in Ovarian Cancer.
Tao Guo, Xue Dong, Shanli Xie, Ling Zhang, Peibin Zeng, Lin Zhang. Cancer Manag Res 2021
Tao Guo, Xue Dong, Shanli Xie, Ling Zhang, Peibin Zeng, Lin Zhang. Cancer Manag Res 2021
Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape.
Xueqin Zou, Yangjing Zhao, Xiuting Liang, Hui Wang, Yanling Zhu, Qixiang Shao. Front Immunol 2021
Xueqin Zou, Yangjing Zhao, Xiuting Liang, Hui Wang, Yanling Zhu, Qixiang Shao. Front Immunol 2021